These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 37001680)

  • 1. HCH6-1, an antagonist of formyl peptide receptor-1, exerts anti-neuroinflammatory and neuroprotective effects in cellular and animal models of Parkinson's disease.
    Wang HL; Cheng YC; Yeh TH; Liu HF; Weng YH; Chen RS; Chen YC; Lu JC; Hwang TL; Wei KC; Liu YC; Wang YT; Hsu CC; Chiu TJ; Chiu CC
    Biochem Pharmacol; 2023 Jun; 212():115524. PubMed ID: 37001680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRP3 mediates the neuroprotective effects of SVHRSP derived from scorpion venom in rotenone-induced experimental Parkinson's disease model.
    Zhang Y; Li S; Hou L; Wu M; Liu J; Wang R; Wang Q; Zhao J
    J Ethnopharmacol; 2023 Aug; 312():116497. PubMed ID: 37072089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
    Que R; Zheng J; Chang Z; Zhang W; Li H; Xie Z; Huang Z; Wang HT; Xu J; Jin D; Yang W; Tan EK; Wang Q
    Front Immunol; 2021; 12():794770. PubMed ID: 34925379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease.
    Gu Y; Hu ZF; Zheng DW; Yang YQ; Dong XL; Chen WF
    Phytomedicine; 2024 Apr; 126():155435. PubMed ID: 38394727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
    Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
    Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720 Inhibits MPP
    Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation.
    Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z
    Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease.
    Pike AF; Longhena F; Faustini G; van Eik JM; Gombert I; Herrebout MAC; Fayed MMHE; Sandre M; Varanita T; Teunissen CE; Hoozemans JJM; Bellucci A; Veerhuis R; Bubacco L
    J Neuroinflammation; 2022 Feb; 19(1):50. PubMed ID: 35172843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease.
    De Araújo FM; Frota AF; de Jesus LB; Macedo TC; Cuenca-Bermejo L; Sanchez-Rodrigo C; Ferreira KMS; de Oliveira JVR; de Fatima Dias Costa M; Segura-Aguilar J; Costa SL; Herrero MT; Silva VDA
    Cell Mol Neurobiol; 2023 Jan; 43(1):265-281. PubMed ID: 34988761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of human umbilical cord mesenchymal stromal cells in PD mice via centrally and peripherally suppressing NLRP3 inflammasome-mediated inflammatory responses.
    Zhou L; Wang X; Wang X; An J; Zheng X; Han D; Chen Z
    Biomed Pharmacother; 2022 Sep; 153():113535. PubMed ID: 36076517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson's disease model.
    Qiu X; Wang Q; Hou L; Zhang C; Wang Q; Zhao X
    Toxicol Lett; 2021 Oct; 349():1-11. PubMed ID: 34052309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson's disease.
    Grotemeyer A; Fischer JF; Koprich JB; Brotchie JM; Blum R; Volkmann J; Ip CW
    J Neuroinflammation; 2023 Mar; 20(1):79. PubMed ID: 36945016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia.
    He XM; Zhou YZ; Sheng S; Li JJ; Wang GQ; Zhang F
    Oxid Med Cell Longev; 2020; 2020():2963540. PubMed ID: 33294118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1.
    Yang SC; Chang SH; Hsieh PW; Huang YT; Ho CM; Tsai YF; Hwang TL
    Free Radic Biol Med; 2017 May; 106():254-269. PubMed ID: 28232203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
    Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
    J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation.
    He Z; Hu Y; Zhang Y; Xie J; Niu Z; Yang G; Zhang J; Zhao Z; Wei S; Wu H; Hu W
    Phytomedicine; 2024 May; 127():155494. PubMed ID: 38471370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson's Disease.
    Chiu YJ; Lin CH; Lin CY; Yang PN; Lo YS; Chen YC; Chen CM; Wu YR; Yao CF; Chang KH; Lee-Chen GJ
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model.
    Qiu J; Chen Y; Zhuo J; Zhang L; Liu J; Wang B; Sun D; Yu S; Lou H
    Neuropharmacology; 2022 Apr; 207():108963. PubMed ID: 35065082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker of Neuroinflammation in Parkinson's Disease.
    Liu TW; Chen CM; Chang KH
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.